Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Lupus

• Publication date

  2014-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0961203314528553PMID 24651669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis

  2013cited by this paper
• Long-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical Practice

  2013cited by this paper
• Long-term multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less cytotoxic therapy.

  2012cited by this paper
• Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial

  2012cited by this paper
• Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis

  2012cited by this paper
• Treatment of young patients with lupus nephritis using calcineurin inhibitors.

  2012cited by this paper
• Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis

  2012cited by this paper
• Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease

  2012cited by this paper
• Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.

  2011cited by this paper
• Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis

  2011cited by this paper
• Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome

  2011cited by this paper
• Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis

  2010cited by this paper
• Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

  2010cited by this paper
• Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.

  2010cited by this paper
• Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis

  2010cited by this paper
• Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis

  2010cited by this paper
• Mizoribine: A New Approach in the Treatment of Renal Disease

  2009cited by this paper
• Clinical Assessment of Tacrolimus Therapy in Lupus Nephritis: One-Year Follow-Up Study in a Single Center

  2009cited by this paper
• Protective Effects of Mizoribine on Cyclosporine A Nephropathy in Rats

  2009cited by this paper
• Successful treatment of class V+IV lupus nephritis with multitarget therapy.

  2008cited by this paper
• Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group

  2008cited by this paper
• Treatment for lupus nephritis: A revisit

  2005cited by this paper
• Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus.

  2000cited by this paper
• Case of Anaphylaxis after Anaesthesia

  1943cited by this paper

• Calcineurin inhibitors for initial induction treatment of lupus nephritis in children

  2025cites this paper
• Long‐term outcome of tacrolimus‐based immunosuppressive treatment for patients with paediatric‐onset lupus nephritis

  2024cites this paper
• Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities

  2023cites this paper
• Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study

  2022cites this paper
• Mizoribine halts kidney fibrosis in childhood IgA nephropathy: association with modulation of M2-type macrophages

  2022cites this paper
• Individualizing Therapy in Lupus Nephritis

  2019cites this paper
• Off‐label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics

  2019cites this paper
• Ethnicity Variation in the Treatment of Pediatric Lupus Nephritis

  2018cites this paper
• Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan

  2018cites this paper
• Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis

  2018cites this paper
• Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy

  2017influential citation
• Calcineurin inhibitors in systemic lupus erythematosus.

  2017cites this paper
• Podocytes as a Direct Target of Drugs Used in Idiopathic Nephrotic Syndrome

  2016cites this paper
• Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

  2016cites this paper
• Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.

  2016cites this paper
• Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome

  2016cites this paper
• Lupus Nephritis in Asia: Clinical Features and Management

  2015cites this paper
• Corticosteroids in Pediatric-Onset SLE and Other Connective Tissue Diseases

  2015cites this paper
• Treatment of severe lupus nephritis: the new horizon

  2015cites this paper
• induction treatment for severe lupus nephritis Study Participants Treatment groups Trial design and duration

  2014cites this paper